ORA - Oxford University Research Archive

You searched for:

Oxford, MSD, Oncology, Biomedical Research Centre, Experimental Medicine Division

Radiopharmaceuticals

1 - 8 of 8

1

Journal article

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.

Gillies, RS, Middleton, MR, Maynard, ND, et al.
2011-02-05

2

Journal article

Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: prevalence and disease pattern.

Chowdhury, FU, Sheerin, F, Bradley, KM, et al.
2009-07-05

3

Journal article

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.

Gillies, RS, Middleton, MR, Blesing, C, et al.
2012-09-05

4

Journal article

The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.

Chowdhury, FU, Bradley, KM, Gleeson, FV
2008-12-05

5

Journal article

Increased sensitivity and confidence of SPECT over planar imaging in dual-phase sestamibi for parathyroid adenoma detection.

Slater, A, Gleeson, FV
2005-01-05

6

Journal article

Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis.

Elkhawad, M, Rudd, JH, Sarov-Blat, L, et al.
2012-09-05

7

Journal article

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.

Gillies, RS, Middleton, MR, Han, C, et al.
2012-02-05

8

Journal article

18F-FDG PET/CT of cervical carcinoma.

Patel, CN, Nazir, SA, Khan, Z, et al.
2011-05-05

TO TOP